Global SiteContact UsShare PriceCareersSearch
ProStrakanAbout UsInvestorsInitiatives
  • SHARE PRICE
  • LATEST DEVELOPMENTS
  • PRESS RELEASES
  • WHO'S WHO
  • PRODUCT TABLE
  • FAQ
  • CORPORATE PRESENTATIONS & GOVERNANCE

We’re not out to conquer the world; we’re just trying to help people get through their day

ProStrakan is unique in that it comprises all the elements necessary for a sustainable pharmaceutical business and is demonstrably successful in each area. Throughout our evolution, we have acquired and merged with a number of companies, some outside of our primary therapeutic focus, but all enabling us to provide help to many more patients.

In 2007, our sales rose 22%, making ProStrakan one of Europe’s fastest growing pharmaceutical companies. With an experienced and respected management team at our helm, this is an exciting time for our company as we move forward into new markets and expand into new patient categories.

 

Leading institutional investors:
Warburg Pincus International Partners LP         
Aventis Pharma SA                                           
Warburg Pincus Private Equity VIII LP              
LMS Capital (Bermuda) Limited                          
Warburg Pincus Equity Partners LP                    
BNY/OCS/Nominees Limited (3i plc)                   
Morstan Nominees Ltd     

         

                

HOME | LEGAL & PRIVACY STATEMENTS

©2009 ProStrakan, Inc.